0001179110-17-008788.txt : 20170609
0001179110-17-008788.hdr.sgml : 20170609
20170609075325
ACCESSION NUMBER: 0001179110-17-008788
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170608
FILED AS OF DATE: 20170609
DATE AS OF CHANGE: 20170609
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BRUKER CORP
CENTRAL INDEX KEY: 0001109354
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 043110160
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 40 MANNING RD
CITY: BILLERICA
STATE: MA
ZIP: 01821
BUSINESS PHONE: 978663-3660
MAIL ADDRESS:
STREET 1: 40 MANNING RD
CITY: BILLERICA
STATE: MA
ZIP: 01821
FORMER COMPANY:
FORMER CONFORMED NAME: BRUKER BIOSCIENCES CORP
DATE OF NAME CHANGE: 20030721
FORMER COMPANY:
FORMER CONFORMED NAME: BRUKER DALTONICS INC
DATE OF NAME CHANGE: 20000315
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Munch Mark
CENTRAL INDEX KEY: 0001544635
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30833
FILM NUMBER: 17901505
MAIL ADDRESS:
STREET 1: BRUKER CORPORATION
STREET 2: 40 MANNING ROAD
CITY: BILLERICA
STATE: MA
ZIP: 01821
4
1
edgar.xml
FORM 4 -
X0306
4
2017-06-08
0
0001109354
BRUKER CORP
BRKR
0001544635
Munch Mark
BRUKER CORPORATION
40 MANNING ROAD
BILLERICA
MA
01821
0
1
0
0
Exec VP&Pres Bruker Nano Inc.
Common Stock
2017-06-08
4
M
0
45177
20.04
A
106602
D
Common Stock
2017-06-08
4
M
0
16144
20.68
A
122746
D
Common Stock
2017-06-08
4
M
0
12403
19.82
A
135149
D
Common Stock
2017-06-08
4
S
0
73724
27.6233
D
61425
D
Stock Option (right to buy)
20.04
2017-06-08
4
M
0
45177
0
D
2023-08-30
Common Stock
45177
15059
D
Stock Option (right to buy)
20.68
2017-06-08
4
M
0
16144
0
D
2024-08-08
Common Stock
16144
16144
D
Stock Option (right to buy)
19.82
2017-06-08
4
M
0
12403
0
D
2025-08-07
Common Stock
12403
37210
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.60 to $27.67, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The options exercised vested in three approximately equal annual installments on August 30, 2014, 2015 and 2016. The remaining options will vest on August 30, 2017.
The options exercised vested in two approximately equal annual installments on August 8, 2015 and 2016. The remaining options will vest in two approximately equal annual installments on each of August 8, 2017 and 2018.
The options exercised vested on August 7, 2016. The remaining options will vest in three approximately equal annual installments on each of August 7, 2017, 2018 and 2019.
/s/Jodi Giordano, Attorney-in-Fact
2017-06-09